| Advantages | They retain defining characteristics of NSCLC, including genetic mutations and protein expression signatures, offering a reliable system for cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Lung |
| Disease | NSCLC (Non-small cell lung cancer) |
| Organoid Characterization | Non-small cell lung cancer (NSCLC) organoids exhibit strong pathological correlation with tumor tissues, expressing key markers such as TTF-1, CK7, p40, and CK5/6. |
| Applications | By maintaining tumor heterogeneity and recapitulating the tumor microenvironment (TME), they enable detailed studies of disease progression and treatment outcomes. As clinically relevant platforms, NSCLC organoids are essential for driving precision oncology and accelerating the development of targeted therapies. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.